Levente
Levente Batizy, Litchfield Park, AZ US
Patent application number | Description | Published |
---|---|---|
20100082452 | ASSOCIATING A PRODUCT WITH A STATIC CATEGORY USING TAGS - Methods of the present invention allow a static product category to be received from a user for a product on an ecommerce site. The user may then be enabled to dynamically associate the product with the static product category using a metadata tag. | 04-01-2010 |
20100082453 | ASSOCIATING A PRODUCT WITH A DYNAMIC CATEGORY USING TAGS - Methods of the present invention allow a user to be enabled to create a metadata tag associated with a product on an ecommerce site. Using the metadata tag, a product category associated with the product may be dynamically created. | 04-01-2010 |
Levente Bodrossy, Toltestava HU
Patent application number | Description | Published |
---|---|---|
20090291854 | Identification of Pathogens - Disclosed is a method for identification of microbial pathogens in a body fluid sample comprising the following steps: a) providing a body fluid sample; b) lysing the microbial pathogens and performing a nucleic acid amplification reaction on the microbial DNA encoding 16S or 18S rRNA wherein or whereafter the amplified nucleic acids are labelled; c) contacting the labelled amplified nucleic acids of step b) with a microarray comprising on defined areas on the microarray's surface immobilised probes for microbial DNA encoding 16S or 18S rRNA from microbial pathogens; d) detecting the binding of one or more species of the labelled amplified nucleic acids to a probe by detecting a labelled amplified nucleic acid being specifically bound to the microarray; and e) identifying a microbial pathogen in the body fluid sample by correlating the detected binding of the labelled amplified nucleic acids with the defined areas of the immobilised probes for microbial DNA encoding 16S or 18S rRNA from microbial pathogens. | 11-26-2009 |
Levente Buttyán, Szentendre HU
Patent application number | Description | Published |
---|---|---|
20150161409 | METHOD AND SYSTEM FOR HANDLING OF GROUP SHARING IN A DISTRIBUTED DATA STORAGE, PARTICULARLY IN P2P ENVIRONMENT - Method and system for handling group sharing in distributed data storage environment, to utilize online unexploited storage space and bandwidth of users. Files of a user are cut into pieces which are then distributed among other online users. The original files are stored retrievably. Key Lock Boxes (KLB) are used for storing keys encrypted. With an authentication and key ex -change protocol a common group key is generated for encrypting a Master Key Lock Box. The Master KLB represents the root of an oriented tree graph, the nodes of the graph represent KLBs. There is an oriented edge between two nodes when a source KLB ( | 06-11-2015 |
Levente Egry, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20130217137 | SYSTEMS AND METHODS FOR PROTEIN MELT ANALYSIS USING DIPYRROMETHENEBORON DIFLUORIDE COMPOUNDS - According to the present teachings, systems and methods for protein melt analysis are provided that utilizing a dye. In some embodiments, a method comprises preparing a sample by mixing at least one protein with a dye, and applying a controlled heating, while recording the fluorescence emission of the sample. | 08-22-2013 |
Levente Emödy, Pécs HU
Patent application number | Description | Published |
---|---|---|
20140303105 | Primycin and components thereof for use in the treatment or prevention of infections caused by specific pathogens - The invention refers to primycin or a primycin component or a combination of primycin components, for use in the treatment or prevention of infections caused by Gram-positive bacteria resistant to methicillin and/or vancomycin and/or mupirocin or by penicillin-resistant streptococci. The invention also covers antibiotic compositions containing these active agents. | 10-09-2014 |
Levente Juhàsz, Nyiregyhaza HU
Patent application number | Description | Published |
---|---|---|
20100080950 | Aroma-therapeutic bedding set - The object of the invention is an aroma-therapeutic bedding set comprising a filling consisting of fibre fleece layers, made of natural or synthetic fibres or a mixture thereof, or fibres placed in an outside ticking, and containing preferably evenly distributed dried and cut herbs embedded in the fibres, or between the layers and embedded in the fibres of the layers. | 04-01-2010 |
Levente Juhàsz, Nyiregyhaza HU
Patent application number | Description | Published |
---|---|---|
20100080950 | Aroma-therapeutic bedding set - The object of the invention is an aroma-therapeutic bedding set comprising a filling consisting of fibre fleece layers, made of natural or synthetic fibres or a mixture thereof, or fibres placed in an outside ticking, and containing preferably evenly distributed dried and cut herbs embedded in the fibres, or between the layers and embedded in the fibres of the layers. | 04-01-2010 |
Levente Kapas, Spokane Valley, WA US
Patent application number | Description | Published |
---|---|---|
20100196396 | COMPOSITIONS AND METHODS FOR MODULATING GHRELIN-MEDIATED CONDITIONS - In certain aspects, the preproghrelin gene, but not the ghrelin receptor (GHS-R1a) is required for normal integration of thermoregulation and sleep in mice. Particular aspects provide methods for modulation of thermoregulation and other ghrelin-mediated conditions (e.g., reduction of appetite or food intake, reduction of body weight or treatment of obesity, reduction of body temperature or induction of hypothermia, etc.), comprising administration of an inhibitor of ghrelin expression, and including, e.g., siRNA inhibition for treatment of obesity and for modulation of thermoregulation (e.g., induction of hypothermia in surgical settings benefiting from same). Additionally provided are methods for reducing body temperature or induction of hypothermia, comprising administration to a mammalian subject in need thereof an amount of an anti-obestatin antibody agent sufficient to reduce body temperature or induce hypothermia. Further methods comprise administration of a ghrelin peptide antagonist. | 08-05-2010 |
Levente Ondi, Horw/lucerne CH
Patent application number | Description | Published |
---|---|---|
20140309466 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS - The invention relates to a method of forming an olefin from a first olefin and a second olefin in a metathesis reaction, comprising step (i): | 10-16-2014 |
20140330018 | METATHESIS CATALYSTS AND METHODS THEREOF - The present application provides, among other things, novel compounds and methods for metathesis reactions. In some embodiments, a provided compound has the structure of formula I. In some embodiments, the present invention provides methods for preparing a compound of formula I. In some embodiments, the present invention provides metathesis methods comprising providing a compound of formula I. | 11-06-2014 |
Levente Ondi, Veresegyhaz HU
Patent application number | Description | Published |
---|---|---|
20140275595 | METHODS FOR TREATING SUBSTRATES PRIOR TO METATHESIS REACTIONS, AND METHODS FOR METATHESIZING SUBSTRATES - A method for treating a substrate prior to a metathesis reaction includes treating the substrate with a first agent configured to mitigate potentially adverse effects of one or more contaminants in the substrate on a catalyst used to catalyze the metathesis reaction. The treating reduces a level of the one or more contaminants by an amount sufficient to enable the metathesis reaction to proceed at a substrate-to-catalyst molar ratio of at least about 7,500 to 1. Methods for metathesizing substrates are described. | 09-18-2014 |
Levente Szuros, Ajak HU
Patent application number | Description | Published |
---|---|---|
20130303472 | SOLID STATE FORMS OF FIDAXOMYCIN AND PROCESSES FOR PREPARATION THEREOF - The present invention provides solid state forms of Fidaxomycin, processes for preparing the solid state forms, as well as pharmaceutical compositions and formulations comprising one or more of the solid state forms of Fidaxomycin, and processes for the preparation of the compositions and formulations. The solid state forms of the present invention exhibit advantageous properties such as improved reliability and reproducibility in manufacturing and processing and stability in formulations. | 11-14-2013 |
20140128334 | Solid State Forms Of Fidaxomycin And Processes For Preparation Thereof - The present invention provides solid state forms of Fidaxomycin, processes for preparing the solid state forms, as well as pharmaceutical compositions and formulations comprising one or more of the solid state forms of Fidaxomycin, and processes for the preparation of the compositions and formulations. The solid state forms of the present invention exhibit advantageous properties such as improved reliability and reproducibility in manufacturing and processing and stability in formulations. | 05-08-2014 |